Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colon

Oncogene

Volumn 27, Issue 46, 2008, Pages 6068-6074

  Lukasiak, S ^a   Schiller, C ^b   Oehlschlaeger, P ^a   Schmidtke, G ^a   Krause, P ^c   Legler, D F ^c   Autschbach, F ^b   Schirmacher, P ^b   Breuhahn, K ^b   Groettrup, M ^a,c  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c UNIVERSITY OF KONSTANZ   (Switzerland)

Author keywords

Colon carcinoma; FAT10; Hepatocellular carcinoma; Interferon ; Ubiquitin like modifiers

Indexed keywords

CYTOKINE; FAT10 PROTEIN; GAMMA INTERFERON; LMP2 PROTEASOME; PROTEASOME; PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CANCER CELL; COLON CANCER; CONTROLLED STUDY; DNA SEQUENCE; EMBRYO; FEMALE; HUMAN; HUMAN CELL; LIVER CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 53649108526     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2008.201     Document Type: Article

References (21)

1. Bates EFM, Ravel O, Dieu MC, Ho S, Guret C, Bridon JM et al. (1997). Identification and analysis of a novel member of the ubiquitin family expressed in dendritic cells and mature B cells. Eur J Immunol 27: 2471-2477.
2. Breuhahn K, Vreden S, Haddad R, Beckebaum S, Stippel D, Flemming P et al. (2004). Molecular profiling of human hepatocellular carcinoma defines mutually exclusive interferon regulation and insulin-like growth factor II overexpression. Cancer Res 64: 6058-6064.
3. Canaan A, Yu XF, Booth CJ, Lian J, Lazar I, Gamfi SL et al. (2006). FAT10/diubiquitin-like protein-deficient mice exhibit minimal phenotypic differences. Mol Cell Biol 26: 5180-5189.
4. Chiu YH, Sun Q, Chen ZJ. (2007). E1-L2 activates both ubiquitin and FAT10. Mol Cell 27: 1014-1023.
5. Fan W, Cai W, Parimoo S, Lennon GG, Weissman SM. (1996). Identification of seven new human MHC class I region genes around the HLA-F locus. Immunogenetics 44: 97-103.
6. Hipp MS, Raasi S, Groettrup M, Schmidtke G. (2004). FAT10, a ubiquitin-independent signal for proteasomal degradation. J Biol Chem 279: 16503-16510.
7. Hipp MS, Kalveram B, Raasi S, Groettrup M, Schmidtke G. (2005). NEDD8 ultimate buster-1L interacts with the ubiquitin-like protein FAT10 and accelerates its degradation. Mol Cell Biol 25: 3483-3491.
8. Kern MA, Breuhahn K, Schirmacher P. (2002). Molecular pathogenesis of human hepatocellular carcinoma. Adv Cancer Res 86: 67-112.
9. Khan S, van den Broek M, Schwarz K, de Giuli R, Diener PA, Groettrup M. (2001). Immunoproteasomes largely replace constitutive proteasomes during an antiviral and antibacterial immune response in the liver. J Immunol 167: 6859-6868.
10. Lee CG, Ren J, Cheong IS, Ban KH, Ooi LL, Yong Tan S et al. (2003). Expression of the FAT10 gene is highly upregulated in hepatocellular carcinoma and other gastrointestinal and gynecological cancers. Oncogene 22: 2592-2603.
11. Legler DF, Krause P, Scandella E, Singer E, Groettrup M. (2006). Prostaglandin E2 is generally required for human dendritic cell migration and exerts its effect via EP2 and EP4 receptors. J Immunol 176: 966-973.
12. Liu Y, Pan J, Zhang C, Fan W, Collinge M, Bender JR et al. (1999). A MHC-encoded ubiquitin-like protein (FAT10) binds noncovalently to the spindle assembly checkpoint protein MAD2. Proc Natl Acad Sci USA 96: 4313-4318.
13. Oliva J, Bardag-Gorce F, French BA, Li J, McPhaul L, Amidi F et al. (2008). FAT10 is an epigenetic marker for liver preneoplasia in a drug-primed mouse model of tumorigenesis. Exp Mol Pathol 84: 102-112.
14. Pfaffl MW, Horgan GW, Dempfle L. (2002). Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30: e36.
15. Raasi S, Schmidtke G, de Giuli R, Groettrup M. (1999). A ubiquitin-like protein which is synergistically inducible by interferon-γ and tumor necrosis factor-α. Eur J Immunol 29: 4030-4036.
16. Raasi S, Schmidtke G, Groettrup M. (2001). The ubiquitin-like protein FAT10 forms covalent conjugates and induces apoptosis. J Biol Chem 276: 35334-35343.
17. Ren JW, Kan A, Leong SH, Ooi LLPJ, Jeang KT, Chong SS et al. (2006). FAT10 plays a role in the regulation of chromosomal stability. J Biol Chem 281: 11413-11421.
18. Ross MJ, Wosnitzer MS, Ross MD, Granelli B, Gusella GL, Husain M et al. (2006). Role of ubiquitin-like protein FAT10 in epithelial apoptosis in renal disease. J Am Soc Nephrol 17: 996-1004.
19. Stohwasser R, Standera S, Peters I, Kloetzel P-M, Groettrup M. (1997). Molecular cloning of the mouse proteasome subunits MC14 and MECL-1: reciprocally regulated tissue expression of interferon-γ-modulated proteasome subunits. Eur J Immunol 27: 1182-1187.
20. Zhang DW, Jeang KT, Lee CGL. (2006). p53 negatively regulates the expression of FAT10, a gene upregulated in various cancers. Oncogene 25: 2318-2327.
21. Zhu LJ, Altmann SW. (2005). mRNA and 18S-RNA coapplication-reverse transcription for quantitative gene expression analysis. Anal Biochem 345: 102-109.